187 related articles for article (PubMed ID: 38522760)
1. The interactions between traditional Chinese medicine and gut microbiota in cancers: Current status and future perspectives.
Wei X; Wang F; Tan P; Huang H; Wang Z; Xie J; Wang L; Liu D; Hu Z
Pharmacol Res; 2024 May; 203():107148. PubMed ID: 38522760
[TBL] [Abstract][Full Text] [Related]
2. The Gut Microbiota and Traditional Chinese Medicine: A New Clinical Frontier on Cancer.
Chen YZ; Yuan MY; Chen YL; Zhang X; Xu XT; Liu SL; Zou X; Tao JL; Qiang YH; Wu J; Sun QM
Curr Drug Targets; 2021; 22(11):1222-1231. PubMed ID: 33845736
[TBL] [Abstract][Full Text] [Related]
3. The linkage of gut microbiota and the property theory of traditional Chinese medicine (TCM): Cold-natured and sweet-flavored TCMs as an example.
Yang Y; Wu C
J Ethnopharmacol; 2023 Apr; 306():116167. PubMed ID: 36641107
[TBL] [Abstract][Full Text] [Related]
4. Traditional Chinese medicine, liver fibrosis, intestinal flora: is there any connection?-a narrative review.
Liu YT; Qi SL; Sun KW
Ann Palliat Med; 2021 Apr; 10(4):4846-4857. PubMed ID: 33832318
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota modulation with traditional Chinese medicine: A system biology-driven approach.
Yue SJ; Wang WX; Yu JG; Chen YY; Shi XQ; Yan D; Zhou GS; Zhang L; Wang CY; Duan JA; Tang YP
Pharmacol Res; 2019 Oct; 148():104453. PubMed ID: 31541688
[TBL] [Abstract][Full Text] [Related]
6. Intestinal Escherichia coli and related dysfunction as potential targets of Traditional Chinese Medicine for respiratory infectious diseases.
Wei L; Zhang L; Zhang Y; Yan L; Liu B; Cao Z; Zhao N; He X; Li L; Lu C
J Ethnopharmacol; 2023 Sep; 313():116381. PubMed ID: 36940735
[TBL] [Abstract][Full Text] [Related]
7. The triangular relationship between traditional Chinese medicines, intestinal flora, and colorectal cancer.
Zou Y; Wang S; Zhang H; Gu Y; Chen H; Huang Z; Yang F; Li W; Chen C; Men L; Tian Q; Xie T
Med Res Rev; 2024 Mar; 44(2):539-567. PubMed ID: 37661373
[TBL] [Abstract][Full Text] [Related]
8. An overview of traditional Chinese medicine affecting gut microbiota in obesity.
Li D; Tang W; Wang Y; Gao Q; Zhang H; Zhang Y; Wang Y; Yang Y; Zhou Y; Zhang Y; Li H; Li S; Zhao H
Front Endocrinol (Lausanne); 2023; 14():1149751. PubMed ID: 36936157
[TBL] [Abstract][Full Text] [Related]
9. The traditional Chinese medicine and non-small cell lung cancer: from a gut microbiome perspective.
Wang X; Hou L; Cui M; Liu J; Wang M; Xie J
Front Cell Infect Microbiol; 2023; 13():1151557. PubMed ID: 37180438
[TBL] [Abstract][Full Text] [Related]
10. The interactions between gut microbiota and bioactive ingredients of traditional Chinese medicines: A review.
Gong X; Li X; Bo A; Shi RY; Li QY; Lei LJ; Zhang L; Li MH
Pharmacol Res; 2020 Jul; 157():104824. PubMed ID: 32344049
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk between traditional Chinese medicine-derived polysaccharides and the gut microbiota: A new perspective to understand traditional Chinese medicine.
Yue B; Zong G; Tao R; Wei Z; Lu Y
Phytother Res; 2022 Nov; 36(11):4125-4138. PubMed ID: 36100366
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of traditional Chinese medicine in modulating gut microbiota metabolites-mediated lipid metabolism.
Li Y; Ji X; Wu H; Li X; Zhang H; Tang D
J Ethnopharmacol; 2021 Oct; 278():114207. PubMed ID: 34000365
[TBL] [Abstract][Full Text] [Related]
13. Gut brain interaction theory reveals gut microbiota mediated neurogenesis and traditional Chinese medicine research strategies.
Zhang C; Xue P; Zhang H; Tan C; Zhao S; Li X; Sun L; Zheng H; Wang J; Zhang B; Lang W
Front Cell Infect Microbiol; 2022; 12():1072341. PubMed ID: 36569198
[TBL] [Abstract][Full Text] [Related]
14. YYFZBJS ameliorates colorectal cancer progression in Apc
Sui H; Zhang L; Gu K; Chai N; Ji Q; Zhou L; Wang Y; Ren J; Yang L; Zhang B; Hu J; Li Q
Cell Commun Signal; 2020 Jul; 18(1):113. PubMed ID: 32677955
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota and integrative traditional Chinese and western medicine in prevention and treatment of heart failure.
Cui H; Han S; Dai Y; Xie W; Zheng R; Sun Y; Xia X; Deng X; Cao Y; Zhang M; Shang H
Phytomedicine; 2023 Aug; 117():154885. PubMed ID: 37302262
[TBL] [Abstract][Full Text] [Related]
16. Role of gut microbiota in identification of novel TCM-derived active metabolites.
Lin TL; Lu CC; Lai WF; Wu TS; Lu JJ; Chen YM; Tzeng CM; Liu HT; Wei H; Lai HC
Protein Cell; 2021 May; 12(5):394-410. PubMed ID: 32929698
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota: A new target of traditional Chinese medicine for insomnia.
Feng W; Yang Z; Liu Y; Chen R; Song Z; Pan G; Zhang Y; Guo Z; Ding X; Chen L; Wang Y
Biomed Pharmacother; 2023 Apr; 160():114344. PubMed ID: 36738504
[TBL] [Abstract][Full Text] [Related]
18. Intestinal Flora: A Pivotal Role in Investigation of Traditional Chinese Medicine.
Li X; Wu D; Niu J; Sun Y; Wang Q; Yang B; Kuang H
Am J Chin Med; 2021; 49(2):237-268. PubMed ID: 33622213
[TBL] [Abstract][Full Text] [Related]
19. Gut Microbiota: The Potential Key Target of TCM's Therapeutic Effect of Treating Different Diseases Using the Same Method-UC and T2DM as Examples.
Zhang B; Liu K; Yang H; Jin Z; Ding Q; Zhao L
Front Cell Infect Microbiol; 2022; 12():855075. PubMed ID: 35433500
[TBL] [Abstract][Full Text] [Related]
20. Exploring global research status and trends in anti-obesity effects of traditional Chinese medicine through intestinal microbiota: a bibliometric study.
Huang W; Wang J; Kuang M; Xiao Z; Fan B; Sun G; Tan Z
Front Cell Infect Microbiol; 2023; 13():1271473. PubMed ID: 38045760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
